Churg-Strauss syndrome and antiasthma therapy [8]

Lancet

Volumn 353, Issue 9158, 1999, Pages 1102-

  Frosi, A ^a   Foresi, A ^a   Bozzoni, M ^a   Ubbiali, A ^a   Vezzoli, F ^a  

^a Ospedale di Sesto San Giovanni   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; MONTELUKAST; PREDNISONE; ZAFIRLUKAST;

ADULT; ANOREXIA; ASTHMA; CASE REPORT; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; DRUG WITHDRAWAL; EPIGASTRIC PAIN; FEMALE; GASTRECTOMY; HUMAN; LETTER; LUNG FUNCTION; NAUSEA; POSTPRANDIAL STATE; PRIORITY JOURNAL; STOMACH HEMORRHAGE; VOMITING; WEIGHT REDUCTION;

EID: 0033608848     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)76464-3     Document Type: Letter

References (5)

1. BJ Lipworth Leukotriene receptor antagonists Lancet 353 1999 57 62
2. A Churg J Churg Steroids and Churg-Strauss syndrome Lancet 352 1998 32 33
3. ME Wechsler E Garpestad SR Flier Pulmonary infiltrates, eosinophilia and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast JAMA 279 1998 455 457
4. A Churg M Brallas SR Cronin J Churg Formes frustes of Churg-Strauss syndrome Chest 108 1995 320 323
5. R Priori M Tomassini L Magrini F Conti G Valesini Churg-Strauss syndrome during pregnancy after steroid withdrawal Lancet 352 1998 1599 1600